217 related articles for article (PubMed ID: 30719171)
1. The Oncogenic Potential of SUV39H2: A Comprehensive and Perspective View.
Li B; Zheng Y; Yang L
J Cancer; 2019; 10(3):721-729. PubMed ID: 30719171
[TBL] [Abstract][Full Text] [Related]
2. SUV39H2/KMT1B Inhibits the cardiomyocyte senescence phenotype by down-regulating BTG2/PC3.
Wang K; Zhu QZ; Ma XT; Cheng C
Aging (Albany NY); 2021 Sep; 13(18):22444-22458. PubMed ID: 34559682
[TBL] [Abstract][Full Text] [Related]
3. SUV39H2 promotes colorectal cancer proliferation and metastasis via tri-methylation of the SLIT1 promoter.
Shuai W; Wu J; Chen S; Liu R; Ye Z; Kuang C; Fu X; Wang G; Li Y; Peng Q; Shi W; Li Y; Zhou Q; Huang W
Cancer Lett; 2018 May; 422():56-69. PubMed ID: 29458143
[TBL] [Abstract][Full Text] [Related]
4. Novel polymorphisms in the SUV39H2 histone methyltransferase and the risk of lung cancer.
Yoon KA; Hwangbo B; Kim IJ; Park S; Kim HS; Kee HJ; Lee JE; Jang YK; Park JG; Lee JS
Carcinogenesis; 2006 Nov; 27(11):2217-22. PubMed ID: 16774942
[TBL] [Abstract][Full Text] [Related]
5. Automethylation of SUV39H2, an oncogenic histone lysine methyltransferase, regulates its binding affinity to substrate proteins.
Piao L; Nakakido M; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2016 Apr; 7(16):22846-56. PubMed ID: 26988914
[TBL] [Abstract][Full Text] [Related]
6. Suppressor of Variegation 3-9 Homolog 2, a Novel Binding Protein of Translationally Controlled Tumor Protein, Regulates Cancer Cell Proliferation.
Kim AR; Sung JY; Rho SB; Kim YN; Yoon K
Biomol Ther (Seoul); 2019 Mar; 27(2):231-239. PubMed ID: 30763986
[TBL] [Abstract][Full Text] [Related]
7. Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.
Zheng Y; Li B; Wang J; Xiong Y; Wang K; Qi Y; Sun H; Wu L; Yang L
Clin Epigenetics; 2018 Oct; 10(1):129. PubMed ID: 30348215
[TBL] [Abstract][Full Text] [Related]
8. N6-methyadenosine modified SUV39H2 regulates homologous recombination through epigenetic repression of DUSP6 in gastric cancer.
Yang J; Xu P; Chen Z; Zhang X; Xia Y; Fang L; Xie L; Li B; Xu Z
Cancer Lett; 2023 Apr; 558():216092. PubMed ID: 36806557
[TBL] [Abstract][Full Text] [Related]
9. Targeting Suppressor of Variegation 3-9 Homologue 2 (SUV39H2) in Acute Lymphoblastic Leukemia (ALL).
Mutonga M; Tamura K; Malnassy G; Fulton N; de Albuquerque A; Hamamoto R; Stock W; Nakamura Y; Alachkar H
Transl Oncol; 2015 Oct; 8(5):368-375. PubMed ID: 26500027
[TBL] [Abstract][Full Text] [Related]
10. Histone methyltransferase SUV39H2 serves oncogenic roles in osteosarcoma.
Piao L; Yuan X; Zhuang M; Qiu X; Xu X; Kong R; Liu Z
Oncol Rep; 2019 Jan; 41(1):325-332. PubMed ID: 30542727
[TBL] [Abstract][Full Text] [Related]
11. Structure, Activity and Function of the Suv39h1 and Suv39h2 Protein Lysine Methyltransferases.
Weirich S; Khella MS; Jeltsch A
Life (Basel); 2021 Jul; 11(7):. PubMed ID: 34357075
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.
Askew EB; Bai S; Parris AB; Minges JT; Wilson EM
Mol Cell Endocrinol; 2017 Mar; 443():42-51. PubMed ID: 28042025
[TBL] [Abstract][Full Text] [Related]
13. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
[TBL] [Abstract][Full Text] [Related]
14. The histone methyltransferase Suv39h2 contributes to nonalcoholic steatohepatitis in mice.
Fan Z; Li L; Li M; Zhang X; Hao C; Yu L; Zeng S; Xu H; Fang M; Shen A; Jenuwein T; Xu Y
Hepatology; 2017 Jun; 65(6):1904-1919. PubMed ID: 28244120
[TBL] [Abstract][Full Text] [Related]
15. Predominant expression of H3K9 methyltransferases in prehypertrophic and hypertrophic chondrocytes during mouse growth plate cartilage development.
Ideno H; Shimada A; Imaizumi K; Kimura H; Abe M; Nakashima K; Nifuji A
Gene Expr Patterns; 2013; 13(3-4):84-90. PubMed ID: 23333759
[TBL] [Abstract][Full Text] [Related]
16. Role of the histone H3 lysine 9 methyltransferase Suv39 h1 in maintaining Epsteinn-Barr virus latency in B95-8 cells.
Imai K; Kamio N; Cueno ME; Saito Y; Inoue H; Saito I; Ochiai K
FEBS J; 2014 May; 281(9):2148-58. PubMed ID: 24588869
[TBL] [Abstract][Full Text] [Related]
17. Promoter histone H3 lysine 9 di-methylation is associated with DNA methylation and aberrant expression of p16 in gastric cancer cells.
Meng CF; Zhu XJ; Peng G; Dai DQ
Oncol Rep; 2009 Nov; 22(5):1221-7. PubMed ID: 19787243
[TBL] [Abstract][Full Text] [Related]
18. Histone methyltransferase SUV39H2 regulates LSD1-dependent CDH1 expression and promotes epithelial mesenchymal transition of osteosarcoma.
Miao Y; Liu G; Liu L
Cancer Cell Int; 2021 Jan; 21(1):2. PubMed ID: 33397384
[TBL] [Abstract][Full Text] [Related]
19. Development of novel SUV39H2 inhibitors that exhibit growth suppressive effects in mouse xenograft models and regulate the phosphorylation of H2AX.
Vougiouklakis T; Saloura V; Park JH; Takamatsu N; Miyamoto T; Nakamura Y; Matsuo Y
Oncotarget; 2018 Aug; 9(61):31820-31831. PubMed ID: 30159125
[TBL] [Abstract][Full Text] [Related]
20. Activity and specificity of the human SUV39H2 protein lysine methyltransferase.
Schuhmacher MK; Kudithipudi S; Kusevic D; Weirich S; Jeltsch A
Biochim Biophys Acta; 2015 Jan; 1849(1):55-63. PubMed ID: 25459750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
